BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37154824)

  • 1. Computational investigation of
    Yousaf MA; Anwer SA; Basheera S; Sivanandan S
    J Biomol Struct Dyn; 2024; 42(4):1901-1923. PubMed ID: 37154824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
    Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potent EGFR-TKD inhibitors from NPACT database through combined computational approaches.
    Mir SA; Muhammad A; Padhiary A; Ekka NJ; Baitharu I; Naik PK; Nayak B
    J Biomol Struct Dyn; 2023; 41(21):12063-12076. PubMed ID: 36695102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of potential bio-molecules from
    Mathpal S; Sharma P; Joshi T; Joshi T; Pande V; Chandra S
    J Biomol Struct Dyn; 2022; 40(20):9885-9896. PubMed ID: 34151733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
    Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
    [No Abstract]   [Full Text] [Related]  

  • 6. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach.
    Siddiqui S; Ahmad R; Alaidarous M; Zia Q; Ahmad Mir S; Alshehri B; Srivastava A; Trivedi A
    J Food Biochem; 2022 May; 46(5):e14062. PubMed ID: 35043973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions.
    Saini N; Grewal AS; Lather V; Gahlawat SK
    Chem Biol Interact; 2022 May; 358():109901. PubMed ID: 35341731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of phytochemicals from
    Yasmeen N; Ahmad Chaudhary A; K Niraj RR; Lakhawat SS; Sharma PK; Kumar V
    J Biomol Struct Dyn; 2023 Dec; ():1-43. PubMed ID: 38141177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tripeptides against tyrosine kinase domain of EGFR for lung cancer cell inhibition by in silico and in vitro studies.
    Kiriwan D; Seetaha S; Jiwacharoenchai N; Tabtimmai L; Sousa SF; Songtawee N; Choowongkomon K
    Chem Biol Drug Des; 2022 Mar; 99(3):456-469. PubMed ID: 34923743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Docking and Simulation-Binding Analysis of Plant Phytochemicals with the Hepatocellular Carcinoma Targets Epidermal Growth Factor Receptor and Caspase-9.
    Mustafa G; Younas S; Mahrosh HS; Albeshr MF; Bhat EA
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Potential IKK-β Inhibitors using Molecular Docking and Molecular Dynamics Techniques for their Anti-cancer Potential.
    Singh SP; Hussain I; Konwar BK; Deka RC; Singh CB
    Curr Comput Aided Drug Des; 2021; 17(1):83-94. PubMed ID: 31899679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods.
    Sharma P; Joshi T; Mathpal S; Joshi T; Pundir H; Chandra S; Tamta S
    J Biomol Struct Dyn; 2022 Apr; 40(6):2757-2768. PubMed ID: 33143552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
    Bultum LE; Tolossa GB; Lee D
    PLoS One; 2022; 17(7):e0270050. PubMed ID: 35895695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening.
    Ornnork N; Kiriwan D; Lirdprapamongkol K; Choowongkomon K; Svasti J; Eurtivong C
    J Mol Graph Model; 2020 Sep; 99():107639. PubMed ID: 32534372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Joshi T; Joshi T; Sharma P; Pundir H; Chandra S
    J Biomol Struct Dyn; 2021 Aug; 39(13):4816-4834. PubMed ID: 32568603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual Screening of
    Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of Bioactive Compounds of Moringa oleifera Leaves with SARS-CoV-2 Proteins to Combat COVID-19 Pathogenesis: a Phytochemical and In Silico Analysis.
    Siddiqui S; Upadhyay S; Ahmad R; Barkat MA; Jamal A; Alothaim AS; Hassan MZ; Rahman MA; Arshad M; Ahamad T; Khan MF; Shankar H; Ali M; Kaleem S; Ahmad J
    Appl Biochem Biotechnol; 2022 Dec; 194(12):5918-5944. PubMed ID: 35838886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 M
    Alagarsamy V; Sundar PS; Narendhar B; Sulthana MT; Kulkarni VS; Aishwarya AD; Solomon VR; Murugesan S; Jubie S; Rohitha K; Dhanwar S
    Med Chem; 2023; 19(9):925-938. PubMed ID: 37069723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico screening of chalcone derivatives as promising EGFR-TK inhibitors for the clinical treatment of cancer.
    Mathpal S; Joshi T; Sharma P; Maiti P; Nand M; Pande V; Chandra S
    3 Biotech; 2024 Jan; 14(1):18. PubMed ID: 38130684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.